Global Neuropathy Pain Treatment Market Growth (Status and Outlook) 2025-2031

March 2025 | 95 pages | ID: G40E1C0FA20EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Neuropathy Pain Treatment market size is predicted to grow from US$ 9161 million in 2025 to US$ 11210 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.

This report studies the Neuropathy Pain Treatment market,

Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathy Pain Treatment is used for Neuropathic pain.

Global Neuropathy Pain Treatment key players include Eli Lilly, Pfizer, etc. Global top two manufacturers hold a share over 65%.

North America is the largest market, with a share about 45%, followed by Asia-Pacific and Europe, both have a share about 50 percent.

In terms of product, Calcium channel alpha 2-delta ligands is the largest segment, with a share about 70%. And in terms of application, the largest application is Retail Pharmacies, followed by Hospitals, etc.

LPI (LP Information)' newest research report, the “Neuropathy Pain Treatment Industry Forecast” looks at past sales and reviews total world Neuropathy Pain Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Neuropathy Pain Treatment sales for 2025 through 2031. With Neuropathy Pain Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neuropathy Pain Treatment industry.

This Insight Report provides a comprehensive analysis of the global Neuropathy Pain Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neuropathy Pain Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neuropathy Pain Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neuropathy Pain Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neuropathy Pain Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Neuropathy Pain Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Calcium Channel Alpha 2-delta Ligands
• Serotonin-norepinephrine Reuptake Inhibitors
• Others

Segmentation by Application:

• Retail Pharmacies
• Hospitals
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Depomed
• Eli Lilly
• Endo
• Grьnenthal Group
• Arbor Pharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Neuropathy Pain Treatment Market Size (2020-2031)
  2.1.2 Neuropathy Pain Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Neuropathy Pain Treatment by Country/Region (2020, 2024 & 2031)
2.2 Neuropathy Pain Treatment Segment by Type
  2.2.1 Calcium Channel Alpha 2-delta Ligands
  2.2.2 Serotonin-norepinephrine Reuptake Inhibitors
  2.2.3 Others
2.3 Neuropathy Pain Treatment Market Size by Type
  2.3.1 Neuropathy Pain Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Neuropathy Pain Treatment Market Size Market Share by Type (2020-2025)
2.4 Neuropathy Pain Treatment Segment by Application
  2.4.1 Retail Pharmacies
  2.4.2 Hospitals
  2.4.3 Others
2.5 Neuropathy Pain Treatment Market Size by Application
  2.5.1 Neuropathy Pain Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Neuropathy Pain Treatment Market Size Market Share by Application (2020-2025)

3 NEUROPATHY PAIN TREATMENT MARKET SIZE BY PLAYER

3.1 Neuropathy Pain Treatment Market Size Market Share by Player
  3.1.1 Global Neuropathy Pain Treatment Revenue by Player (2020-2025)
  3.1.2 Global Neuropathy Pain Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Neuropathy Pain Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NEUROPATHY PAIN TREATMENT BY REGION

4.1 Neuropathy Pain Treatment Market Size by Region (2020-2025)
4.2 Global Neuropathy Pain Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Neuropathy Pain Treatment Market Size Growth (2020-2025)
4.4 APAC Neuropathy Pain Treatment Market Size Growth (2020-2025)
4.5 Europe Neuropathy Pain Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Neuropathy Pain Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Neuropathy Pain Treatment Market Size by Country (2020-2025)
5.2 Americas Neuropathy Pain Treatment Market Size by Type (2020-2025)
5.3 Americas Neuropathy Pain Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Neuropathy Pain Treatment Market Size by Region (2020-2025)
6.2 APAC Neuropathy Pain Treatment Market Size by Type (2020-2025)
6.3 APAC Neuropathy Pain Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Neuropathy Pain Treatment Market Size by Country (2020-2025)
7.2 Europe Neuropathy Pain Treatment Market Size by Type (2020-2025)
7.3 Europe Neuropathy Pain Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Neuropathy Pain Treatment by Region (2020-2025)
8.2 Middle East & Africa Neuropathy Pain Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Neuropathy Pain Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NEUROPATHY PAIN TREATMENT MARKET FORECAST

10.1 Global Neuropathy Pain Treatment Forecast by Region (2026-2031)
  10.1.1 Global Neuropathy Pain Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Neuropathy Pain Treatment Forecast
  10.1.3 APAC Neuropathy Pain Treatment Forecast
  10.1.4 Europe Neuropathy Pain Treatment Forecast
  10.1.5 Middle East & Africa Neuropathy Pain Treatment Forecast
10.2 Americas Neuropathy Pain Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Neuropathy Pain Treatment Forecast
  10.2.2 Canada Market Neuropathy Pain Treatment Forecast
  10.2.3 Mexico Market Neuropathy Pain Treatment Forecast
  10.2.4 Brazil Market Neuropathy Pain Treatment Forecast
10.3 APAC Neuropathy Pain Treatment Forecast by Region (2026-2031)
  10.3.1 China Neuropathy Pain Treatment Market Forecast
  10.3.2 Japan Market Neuropathy Pain Treatment Forecast
  10.3.3 Korea Market Neuropathy Pain Treatment Forecast
  10.3.4 Southeast Asia Market Neuropathy Pain Treatment Forecast
  10.3.5 India Market Neuropathy Pain Treatment Forecast
  10.3.6 Australia Market Neuropathy Pain Treatment Forecast
10.4 Europe Neuropathy Pain Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Neuropathy Pain Treatment Forecast
  10.4.2 France Market Neuropathy Pain Treatment Forecast
  10.4.3 UK Market Neuropathy Pain Treatment Forecast
  10.4.4 Italy Market Neuropathy Pain Treatment Forecast
  10.4.5 Russia Market Neuropathy Pain Treatment Forecast
10.5 Middle East & Africa Neuropathy Pain Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Neuropathy Pain Treatment Forecast
  10.5.2 South Africa Market Neuropathy Pain Treatment Forecast
  10.5.3 Israel Market Neuropathy Pain Treatment Forecast
  10.5.4 Turkey Market Neuropathy Pain Treatment Forecast
10.6 Global Neuropathy Pain Treatment Forecast by Type (2026-2031)
10.7 Global Neuropathy Pain Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Neuropathy Pain Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Neuropathy Pain Treatment Product Offered
  11.1.3 Pfizer Neuropathy Pain Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Depomed
  11.2.1 Depomed Company Information
  11.2.2 Depomed Neuropathy Pain Treatment Product Offered
  11.2.3 Depomed Neuropathy Pain Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Depomed Main Business Overview
  11.2.5 Depomed Latest Developments
11.3 Eli Lilly
  11.3.1 Eli Lilly Company Information
  11.3.2 Eli Lilly Neuropathy Pain Treatment Product Offered
  11.3.3 Eli Lilly Neuropathy Pain Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Eli Lilly Main Business Overview
  11.3.5 Eli Lilly Latest Developments
11.4 Endo
  11.4.1 Endo Company Information
  11.4.2 Endo Neuropathy Pain Treatment Product Offered
  11.4.3 Endo Neuropathy Pain Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Endo Main Business Overview
  11.4.5 Endo Latest Developments
11.5 Grьnenthal Group
  11.5.1 Grьnenthal Group Company Information
  11.5.2 Grьnenthal Group Neuropathy Pain Treatment Product Offered
  11.5.3 Grьnenthal Group Neuropathy Pain Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Grьnenthal Group Main Business Overview
  11.5.5 Grьnenthal Group Latest Developments
11.6 Arbor Pharmaceuticals
  11.6.1 Arbor Pharmaceuticals Company Information
  11.6.2 Arbor Pharmaceuticals Neuropathy Pain Treatment Product Offered
  11.6.3 Arbor Pharmaceuticals Neuropathy Pain Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Arbor Pharmaceuticals Main Business Overview
  11.6.5 Arbor Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Neuropathy Pain Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Neuropathy Pain Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Calcium Channel Alpha 2-delta Ligands
Table 4. Major Players of Serotonin-norepinephrine Reuptake Inhibitors
Table 5. Major Players of Others
Table 6. Neuropathy Pain Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Neuropathy Pain Treatment Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Neuropathy Pain Treatment Market Size Market Share by Type (2020-2025)
Table 9. Neuropathy Pain Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Neuropathy Pain Treatment Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Neuropathy Pain Treatment Market Size Market Share by Application (2020-2025)
Table 12. Global Neuropathy Pain Treatment Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Neuropathy Pain Treatment Revenue Market Share by Player (2020-2025)
Table 14. Neuropathy Pain Treatment Key Players Head office and Products Offered
Table 15. Neuropathy Pain Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Neuropathy Pain Treatment Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Neuropathy Pain Treatment Market Size Market Share by Region (2020-2025)
Table 20. Global Neuropathy Pain Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Neuropathy Pain Treatment Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Neuropathy Pain Treatment Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Neuropathy Pain Treatment Market Size Market Share by Country (2020-2025)
Table 24. Americas Neuropathy Pain Treatment Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Neuropathy Pain Treatment Market Size Market Share by Type (2020-2025)
Table 26. Americas Neuropathy Pain Treatment Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Neuropathy Pain Treatment Market Size Market Share by Application (2020-2025)
Table 28. APAC Neuropathy Pain Treatment Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Neuropathy Pain Treatment Market Size Market Share by Region (2020-2025)
Table 30. APAC Neuropathy Pain Treatment Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Neuropathy Pain Treatment Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Neuropathy Pain Treatment Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Neuropathy Pain Treatment Market Size Market Share by Country (2020-2025)
Table 34. Europe Neuropathy Pain Treatment Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Neuropathy Pain Treatment Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Neuropathy Pain Treatment Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Neuropathy Pain Treatment Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Neuropathy Pain Treatment Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Neuropathy Pain Treatment
Table 40. Key Market Challenges & Risks of Neuropathy Pain Treatment
Table 41. Key Industry Trends of Neuropathy Pain Treatment
Table 42. Global Neuropathy Pain Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Neuropathy Pain Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Neuropathy Pain Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Neuropathy Pain Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Pfizer Details, Company Type, Neuropathy Pain Treatment Area Served and Its Competitors
Table 47. Pfizer Neuropathy Pain Treatment Product Offered
Table 48. Pfizer Neuropathy Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Pfizer Main Business
Table 50. Pfizer Latest Developments
Table 51. Depomed Details, Company Type, Neuropathy Pain Treatment Area Served and Its Competitors
Table 52. Depomed Neuropathy Pain Treatment Product Offered
Table 53. Depomed Neuropathy Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Depomed Main Business
Table 55. Depomed Latest Developments
Table 56. Eli Lilly Details, Company Type, Neuropathy Pain Treatment Area Served and Its Competitors
Table 57. Eli Lilly Neuropathy Pain Treatment Product Offered
Table 58. Eli Lilly Neuropathy Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Eli Lilly Main Business
Table 60. Eli Lilly Latest Developments
Table 61. Endo Details, Company Type, Neuropathy Pain Treatment Area Served and Its Competitors
Table 62. Endo Neuropathy Pain Treatment Product Offered
Table 63. Endo Neuropathy Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Endo Main Business
Table 65. Endo Latest Developments
Table 66. Grьnenthal Group Details, Company Type, Neuropathy Pain Treatment Area Served and Its Competitors
Table 67. Grьnenthal Group Neuropathy Pain Treatment Product Offered
Table 68. Grьnenthal Group Neuropathy Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Grьnenthal Group Main Business
Table 70. Grьnenthal Group Latest Developments
Table 71. Arbor Pharmaceuticals Details, Company Type, Neuropathy Pain Treatment Area Served and Its Competitors
Table 72. Arbor Pharmaceuticals Neuropathy Pain Treatment Product Offered
Table 73. Arbor Pharmaceuticals Neuropathy Pain Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Arbor Pharmaceuticals Main Business
Table 75. Arbor Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Neuropathy Pain Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neuropathy Pain Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Neuropathy Pain Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Neuropathy Pain Treatment Sales Market Share by Country/Region (2024)
Figure 8. Neuropathy Pain Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Neuropathy Pain Treatment Market Size Market Share by Type in 2024
Figure 10. Neuropathy Pain Treatment in Retail Pharmacies
Figure 11. Global Neuropathy Pain Treatment Market: Retail Pharmacies (2020-2025) & ($ millions)
Figure 12. Neuropathy Pain Treatment in Hospitals
Figure 13. Global Neuropathy Pain Treatment Market: Hospitals (2020-2025) & ($ millions)
Figure 14. Neuropathy Pain Treatment in Others
Figure 15. Global Neuropathy Pain Treatment Market: Others (2020-2025) & ($ millions)
Figure 16. Global Neuropathy Pain Treatment Market Size Market Share by Application in 2024
Figure 17. Global Neuropathy Pain Treatment Revenue Market Share by Player in 2024
Figure 18. Global Neuropathy Pain Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Neuropathy Pain Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Neuropathy Pain Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Neuropathy Pain Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Neuropathy Pain Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Neuropathy Pain Treatment Value Market Share by Country in 2024
Figure 24. United States Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Neuropathy Pain Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Neuropathy Pain Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Neuropathy Pain Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Neuropathy Pain Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Neuropathy Pain Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Neuropathy Pain Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Neuropathy Pain Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Neuropathy Pain Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Neuropathy Pain Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Neuropathy Pain Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Neuropathy Pain Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Neuropathy Pain Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Neuropathy Pain Treatment Market Size 2026-2031 ($ millions)